SEC Form D · Amendment · filed December 16, 2025
Imbria Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Zina Affas Besse · Woodland Hills, CADirectorKen Horne · Boston, MADirectorAndrew Levin · Boston, MADirectorAlvin Shih · Boston, MAExec · DirectorEdward Gillespie · Houston, TXExec · DirectorAlvin Shih · Boston, MAExec · DirectorCharles Dunn · Boston, MADirectorAndrew Levin · Boston, MADirectorKomal Joshi · Boston, MAExecPeter Longo · Houston, TXDirectorLucie Harwood · Houston, TXDirectorPavan Cheruvu · Boston, MADirectorKomal Joshi · Boston, MAExecLuse Rebecca · Boston, MADirectorLuse Rebecca · Boston, MADirectorCharles Dunn · Boston, MADirectorPavan Cheruvu · Boston, MADirectorKen Horne · Boston, MADirectorZina Affas Besse · Woodland Hills, CADirectorKeith Grimes · Houston, TXExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗